Characteristics and clinical outcomes of patients with cardiogenic shock complicating acute myocardial infarction treated by emergent coronary angioplasty

International Journal of Cardiovascular Interventions

Volumn 7, Issue 4, 2005, Pages 193-198

  Assali, Abid R ^a,b   Iakobishvili, Zaza ^a,b   Zafrir, Nili ^a,b   Solodky, Alejandro ^a,b   Teplitsky, Igal ^a,b   Rechavia, Eldad ^a,b   Butto, Nader ^a,b   Shor, Nurit ^a,b   Hasdai, David ^a,b   Fuchs, Shmuel ^a,b   Battler, Alexander ^a,b   Kornowski, Ran ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Angioplasty; Cardiogenic shock; Myocardial infarction; Stents

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOGENIC SHOCK; CAUSE OF DEATH; CLINICAL ARTICLE; COHORT ANALYSIS; COMORBIDITY; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA ANALYSIS; DATA BASE; DEATH; EVALUATION; FEMALE; GROUPS BY AGE; HEALTH CENTER; HEART CATHETERIZATION; HELP SEEKING BEHAVIOR; HOSPITALIZATION; HUMAN; LABORATORY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; ONSET AGE; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; REFRACTORY PERIOD; RISK; SEX DIFFERENCE; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SHOCK, CARDIOGENIC; TREATMENT OUTCOME;

EID: 29844439578     PISSN: 14628848     EISSN: 14711796     Source Type: Journal    
DOI: 10.1080/14628840500445566     Document Type: Article

References (18)

1. Goldberg RJ, Samad NA, Yarzebski J, Gurwitz J, Bigelow C, Gore JM. Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med. 1999;340:1162-8.
2. Carnendran L, Abboud R, Sleeper LA, et al. Trends in cardiogenic shock: report from the SHOCK study. Eur Heart J. 2001;22:472-8.
3. Holmes DR Jr, Bates ER, Kleiman NS, et al. Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. The GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol. 1995;26:668-74.
4. Ashby DT, Stone GW, Moses JW. Cardiogenic shock in acute myocardial infarction. Catheter Cardiovasc Interv. 2003;59:34-43.
5. Giri S, Mitchel J, Azar RR, et al. Results of primary percutaneous transluminal coronary angioplasty plus abciximab with or without stenting for acute myocardial infarction complicated by cardiogenic shock. Am J Cardiol. 2002;89:126-31.
6. Chan AW, Chew DP, Bhatt DL, Moliterno DJ, Topol EJ, Ellis SG. Long-term mortality benefit with the combination of stents and abciximab for cardiogenic shock complicating acute myocardial infarction. Am J Cardiol. 2002;89:132-6.
7. Antoniucci D, Valenti R, Migliorini A, et al. Abciximab therapy improves survival in patients with acute myocardial infarction complicated by early cardiogenic shock undergoing coronary artery stent implantation. Am J Cardiol. 2002;90:353-7.
8. Hasdai D, Harrington RA, Hochman JS, et al. Platelet glycoprotein IIb/IIIa blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevation. J Am Coll Cardiol. 2000;36:685-92.
9. Huang R, Sacks J, Thai H, et al. Impact of stents and abciximab on survival from cardiogenic shock treated with percutaneous coronary intervention. Catheter Cardiovasc Interv. 2005;65:25-33.
10. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction; A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of patients with acute myocardial infarction). J Am Coll Cardiol. 2004;44:E1-E211.
11. Iakobishvili Z, Behar S, Boyko V, Battler A, Hasdai D. Does current treatment of cardiogenic shock complicating the acute coronary syndromes comply with guidelines? Am Heart J. 2005;149:98-103.
12. Dauerman H, Goldberg RJ, White K, et al. Revascularization, stenting, and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. Am J Cardiol. 2002;90:838-42.
13. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med. 1999;341:625-34.
14. Sanborn TA, Sleeper LA, Bates ER, et al. Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. J Am Coll Cardiol. 2000;36:1123-9.
15. Rogers WJ, Canto JG, Lambrew CT, et al. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999:the National registry of Myocardial Infarction 1, 2 and 3. J Am Coll Cardiol. 2000;36:2056-66.
16. Zeymer U, Tebbe U, Weber M, et al. Prospective Evaluation of Early Abciximab and Primary Percutaneous Intervention for Patients with ST elevation Myocardial Infarction Complicated by Cardiogenic Shock: Results of the REOSHOCK Trial. J Invasive Cardiol. 2003;15:385-9.
17. Karcz M, Bekta P, Kepka C, et al. Acute myocardial infarction complicated by cardiogenic shock. In-hospital and mid-term results of invasive treatment in the National Institute of Cardiology, Warsaw-Anin. Kardiol Pol. 2003;58:366-74.
18. Dzavik V, Sleeper LA, Picard MH, et al. Should we emergently revascularize Occluded Coronaries in cardiogenic shock Investigators. Outcome of patients aged > or = 75 years in the should we emergently revascularize Occluded Coronaries in cardiogenic shock (SHOCK) trial: do elderly patients with acute myocardial infarction complicated by cardiogenic shock respond differently to emergent revascularization? Am Heart J. 2005;149:1128-34.